Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Arrhythmias

  Free Subscription


Articles published in J Thromb Thrombolysis

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    October 2021
  1. LV WH, Dong JZ, Du X, Hu R, et al
    Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndrome.
    J Thromb Thrombolysis. 2021 Oct 22. pii: 10.1007/s11239-021-02588.
    PubMed     Abstract available


    September 2021
  2. PAPANASTASIOU A, Kartas A, Samaras A, Vrana E, et al
    Oral anticoagulation patterns and prognosis in octogenarian patients with atrial fibrillation.
    J Thromb Thrombolysis. 2021 Sep 25. pii: 10.1007/s11239-021-02571.
    PubMed     Abstract available


  3. WANG CL, Wu VC, Tu HT, Huang YT, et al
    Risk of major bleeding associated with concomitant use of anticancer drugs and direct oral anticoagulant in patients with cancer and atrial fibrillation.
    J Thromb Thrombolysis. 2021 Sep 23. pii: 10.1007/s11239-021-02570.
    PubMed     Abstract available


  4. OBI CA, Bulsara K, Izard S, Delicce A, et al
    Examination of anticoagulation prescription among elderly patients with atrial fibrillation after in-hospital fall.
    J Thromb Thrombolysis. 2021 Sep 4. pii: 10.1007/s11239-021-02555.
    PubMed     Abstract available


  5. CHEN J, Zhou M, Wang H, Zheng Z, et al
    Risk factors for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc score.
    J Thromb Thrombolysis. 2021 Sep 2. pii: 10.1007/s11239-021-02554.
    PubMed     Abstract available


    August 2021
  6. MENDOZA PA, McIntyre WF, Belley-Cote EP, Wang J, et al
    Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis.
    J Thromb Thrombolysis. 2021 Aug 2. pii: 10.1007/s11239-021-02530.
    PubMed     Abstract available


    July 2021
  7. LI RJ, Caughey GE, Shakib S
    Appropriateness of inpatient dosing of direct oral anticoagulants for atrial fibrillation.
    J Thromb Thrombolysis. 2021 Jul 24. pii: 10.1007/s11239-021-02528.
    PubMed     Abstract available


    June 2021
  8. LU X, Chen T, Liu G, Guo Y, et al
    Relations between left atrial appendage contrast retention and thromboembolic risk in patients with atrial fibrillation.
    J Thromb Thrombolysis. 2021 Jun 15. pii: 10.1007/s11239-021-02490.
    PubMed     Abstract available


    May 2021
  9. PIAZZA G, Hurwitz S, Goldhaber SZ
    Stroke risk factors and outcomes among hospitalized women with atrial fibrillation.
    J Thromb Thrombolysis. 2021 May 26. pii: 10.1007/s11239-021-02482.
    PubMed     Abstract available


  10. BERNAITIS N, Badrick T, Anoopkumar-Dukie S
    Comparison of potential pharmacokinetic drug interactions in patients with atrial fibrillation and changing from warfarin to non-vitamin K oral anticoagulant therapy.
    J Thromb Thrombolysis. 2021 May 7. pii: 10.1007/s11239-021-02466.
    PubMed     Abstract available


    April 2021
  11. VINEREANU D, Napalkov D, Bergler-Klein J, Benczur B, et al
    Patient perceptions of anticoagulant treatment with dabigatran or a vitamin K antagonist for stroke prevention in atrial fibrillation according to region and age: an exploratory analysis from the RE-SONANCE study.
    J Thromb Thrombolysis. 2021 Apr 30. pii: 10.1007/s11239-021-02450.
    PubMed     Abstract available


  12. BARTOLAZZI F, Ribeiro ALP, de Sousa WJFN, Vianna MS, et al
    Relationship of health literacy and adherence to oral anticoagulation therapy in patients with atrial fibrillation: a cross-sectional study.
    J Thromb Thrombolysis. 2021 Apr 15. pii: 10.1007/s11239-021-02432.
    PubMed     Abstract available


    February 2021
  13. LIVNEH N, Braeken D, Drozdinsky G, Gafter-Gvili A, et al
    Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy.
    J Thromb Thrombolysis. 2021 Feb 1. pii: 10.1007/s11239-021-02393.
    PubMed     Abstract available


  14. GAVIN O, Grandes J, Garcia MA, Marzo C, et al
    Treatment preferences as basis for decision making in patients using direct oral anticoagulants in Spain.
    J Thromb Thrombolysis. 2021;51:475-484.
    PubMed     Abstract available


    January 2021
  15. FENG Y, Pai CW, Seiler K, Barnes GD, et al
    Adverse outcomes associated with inappropriate direct oral anticoagulant starter pack prescription among patients with atrial fibrillation: a retrospective claims-based study.
    J Thromb Thrombolysis. 2021 Jan 3. pii: 10.1007/s11239-020-02358.
    PubMed     Abstract available


  16. NABAVIZADEH P, Steen DL
    Highlights from the European society of cardiology congress 2020.
    J Thromb Thrombolysis. 2021;51:232-236.
    PubMed    


    November 2020
  17. DING WY, Lip GYH, Bartoletti S, Morrison L, et al
    Long-term outcomes of left atrial appendage occlusion in high-risk atrial fibrillation patients: 4-year follow up data.
    J Thromb Thrombolysis. 2020 Nov 9. pii: 10.1007/s11239-020-02333.
    PubMed     Abstract available


    October 2020
  18. MARIANI MV, Magnocavallo M, Straito M, Piro A, et al
    Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis.
    J Thromb Thrombolysis. 2020 Oct 12. pii: 10.1007/s11239-020-02304.
    PubMed     Abstract available


    September 2020
  19. PIAZZA G, Hurwitz S, Carroll B, Goldhaber SZ, et al
    Patients with perceived high-bleeding risk and computerized decision support for stroke prevention in atrial fibrillation: an AF-ALERT substudy : Piazza: outcomes of high-bleeding risk AF patients.
    J Thromb Thrombolysis. 2020 Sep 30. pii: 10.1007/s11239-020-02296.
    PubMed     Abstract available


  20. HUANG K, Zha M, Gao J, Du J, et al
    Increased intracranial hemorrhage of mechanical thrombectomy in acute ischemic stroke patients with atrial fibrillation.
    J Thromb Thrombolysis. 2020 Sep 12. pii: 10.1007/s11239-020-02269.
    PubMed     Abstract available


    July 2020
  21. MOHAMED MFH, Elewa H, Mubasher M, Danjuma M, et al
    Direct oral anticoagulants are effective and safe in the treatment of venous thromboembolism and atrial fibrillation in morbidly obese patients.
    J Thromb Thrombolysis. 2020 Jul 31. pii: 10.1007/s11239-020-02238.
    PubMed    


  22. CAPPELLARI M, Forlivesi S, Zucchella C, Valbusa V, et al
    Factors influencing cognitive performance after 1-year treatment with direct oral anticoagulant in patients with atrial fibrillation and previous ischemic stroke: a pilot study.
    J Thromb Thrombolysis. 2020 Jul 29. pii: 10.1007/s11239-020-02233.
    PubMed     Abstract available


  23. DIEP R, Garcia D
    Should we monitor the direct oral anticoagulants?
    J Thromb Thrombolysis. 2020;50:30-32.
    PubMed    


    June 2020
  24. AMIN A, Keshishian A, Dina O, Dhamane A, et al
    Correction to: Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS Medicare population.
    J Thromb Thrombolysis. 2020 Jun 20. pii: 10.1007/s11239-020-02161.
    PubMed     Abstract available


  25. TZEIS S, Savvari P, Skiadas I, Patsilinakos S, et al
    Right drug, wrong dosage: insights from the PAVE-AF antithrombotic study in older patients with atrial fibrillation.
    J Thromb Thrombolysis. 2020 Jun 9. pii: 10.1007/s11239-020-02167.
    PubMed     Abstract available


    May 2020
  26. LV MN, Zheng XC, Zhang HQ, Xu FD, et al
    Comparison of clinical performance of four gastrointestinal bleeding risk scores in Chinese patients with atrial fibrillation receiving oral anticoagulants.
    J Thromb Thrombolysis. 2020 May 27. pii: 10.1007/s11239-020-02152.
    PubMed     Abstract available


  27. SANTORO F, Brunetti ND, Rillig A, Reissmann B, et al
    Stroke and left atrial thrombi after cryoballoon ablation of atrial fibrillation: incidence and predictors. Results from a long-term follow-up.
    J Thromb Thrombolysis. 2020 May 23. pii: 10.1007/s11239-020-02148.
    PubMed     Abstract available


  28. WANG CL, Wu VC, Huang YT, Chen YL, et al
    Incidence and consequences of resuming oral anticoagulant therapy following hematuria and risks of ischemic stroke and major bleeding in patients with atrial fibrillation.
    J Thromb Thrombolysis. 2020 May 14. pii: 10.1007/s11239-020-02135.
    PubMed     Abstract available


  29. DUARTE RCF, Rios DRA, Figueiredo EL, Caiaffa JRS, et al
    Thrombin Generation and other hemostatic parameters in patients with atrial fibrillation in use of warfarin or rivaroxaban.
    J Thromb Thrombolysis. 2020 May 6. pii: 10.1007/s11239-020-02126.
    PubMed     Abstract available


  30. NEHAJ F, Sokol J, Ivankova J, Mokan M, et al
    Edoxaban affects TRAP-dependent platelet aggregation.
    J Thromb Thrombolysis. 2020;49:578-583.
    PubMed     Abstract available


    April 2020
  31. ZHANG L, Yan X, Fox KAA, Willmann S, et al
    Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation.
    J Thromb Thrombolysis. 2020 Apr 23. pii: 10.1007/s11239-020-02077.
    PubMed     Abstract available


  32. LIU W, Xiong N, Xie K, Wu B, et al
    A stricter control of low-density lipoprotein is necessary for thrombosis reduction in "lower thrombosis risk" patients with atrial fibrillation: a multicenter retrospective cohort study.
    J Thromb Thrombolysis. 2020 Apr 13. pii: 10.1007/s11239-020-02110.
    PubMed     Abstract available


  33. TOSELLI M, Bosi D, Benatti G, Solinas E, et al
    Left atrial appendage closure: a balanced management of the thromboembolic risk in patients with hemophilia and atrial fibrillation.
    J Thromb Thrombolysis. 2020 Apr 8. pii: 10.1007/s11239-020-02097.
    PubMed     Abstract available


  34. BO M, Brunetti E, Gibello M
    Underuse of anticoagulant therapy in hospitalized older patients: comment on the article of Wojszel et al.
    J Thromb Thrombolysis. 2020;49:499-500.
    PubMed    


    February 2020
  35. BERNSTEIN MR, John L, Sciortino S, Arambages E, et al
    Does telehealth improve anticoagulation management in patient service centers (PSC)? A pilot project.
    J Thromb Thrombolysis. 2020;49:316-320.
    PubMed     Abstract available


  36. VEDOVATI MC, Mosconi MG, Isidori F, Agnelli G, et al
    Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study.
    J Thromb Thrombolysis. 2020;49:251-258.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: